552 related articles for article (PubMed ID: 34702294)
1. HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.
Saito A; Yamashita M
Retrovirology; 2021 Oct; 18(1):32. PubMed ID: 34702294
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Maturation: Lessons Learned from Inhibitors.
Kleinpeter AB; Freed EO
Viruses; 2020 Aug; 12(9):. PubMed ID: 32858867
[TBL] [Abstract][Full Text] [Related]
3. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
[TBL] [Abstract][Full Text] [Related]
4. A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.
Siddiqui MA; Saito A; Halambage UD; Ferhadian D; Fischer DK; Francis AC; Melikyan GB; Ambrose Z; Aiken C; Yamashita M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167922
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
Zhou J; Price AJ; Halambage UD; James LC; Aiken C
J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells.
Zila V; Müller TG; Laketa V; Müller B; Kräusslich HG
mBio; 2019 Nov; 10(6):. PubMed ID: 31690677
[TBL] [Abstract][Full Text] [Related]
7. Capsid proteins of enveloped viruses as antiviral drug targets.
Klumpp K; Crépin T
Curr Opin Virol; 2014 Apr; 5():63-71. PubMed ID: 24607800
[TBL] [Abstract][Full Text] [Related]
8. Capsid-Dependent Host Factors in HIV-1 Infection.
Yamashita M; Engelman AN
Trends Microbiol; 2017 Sep; 25(9):741-755. PubMed ID: 28528781
[TBL] [Abstract][Full Text] [Related]
9. Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.
Saito A; Ferhadian D; Sowd GA; Serrao E; Shi J; Halambage UD; Teng S; Soto J; Siddiqui MA; Engelman AN; Aiken C; Yamashita M
J Virol; 2016 Jun; 90(12):5808-5823. PubMed ID: 27076642
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
[TBL] [Abstract][Full Text] [Related]
11. Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms.
Gallay PA; Ptak RG; Bobardt MD; Dumont JM; Vuagniaux G; Rosenwirth B
Viruses; 2013 Mar; 5(3):981-97. PubMed ID: 23524389
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 capsid: the multifaceted key player in HIV-1 infection.
Campbell EM; Hope TJ
Nat Rev Microbiol; 2015 Aug; 13(8):471-83. PubMed ID: 26179359
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 capsid and viral DNA integration.
Dwivedi R; Prakash P; Kumbhar BV; Balasubramaniam M; Dash C
mBio; 2024 Jan; 15(1):e0021222. PubMed ID: 38085100
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
Thenin-Houssier S; Valente ST
Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
[TBL] [Abstract][Full Text] [Related]
16. Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors.
Wilbourne M; Zhang P
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557422
[TBL] [Abstract][Full Text] [Related]
17. Roles of HIV-1 capsid in viral replication and immune evasion.
Le Sage V; Mouland AJ; Valiente-Echeverría F
Virus Res; 2014 Nov; 193():116-29. PubMed ID: 25036886
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
Shi J; Zhou J; Shah VB; Aiken C; Whitby K
J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
[TBL] [Abstract][Full Text] [Related]
19. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
Hulme AE; Kelley Z; Foley D; Hope TJ
J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
[TBL] [Abstract][Full Text] [Related]
20. Off-Pathway Assembly: A Broad-Spectrum Mechanism of Action for Drugs That Undermine Controlled HIV-1 Viral Capsid Formation.
Pak AJ; Grime JMA; Yu A; Voth GA
J Am Chem Soc; 2019 Jul; 141(26):10214-10224. PubMed ID: 31244184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
